- Post results briefing, we are upbeat on Riverstone. Its growth prospects remain intact, premised on the recovery of global semiconductor sales and improving market dynamics within the healthcare glove industry.
- - Read this at SGinvestors.io -
Key operating metrics.
- To recap, Riverstone’s cleanroom glove (CG) ASPs inched up to US$94/1,000 pieces from US$90/1000 pieces. Healthcare glove (HG) ASPs rose to US$28.50, up from US$26-27, on a favourable product mix.
- Moving forward, we expect cleanroom glove ASP to be flattish or see a mild increase as the bulk of the price has been locked in on a periodic basis. Healthcare glove is expected to remain rangebound as well, due to the higher product mix towards the generic segment (driven by industry recovery trend and trade diversion).
- - Read this at SGinvestors.io -
Margins.
- Read more at SGinvestors.io.
Singapore Research RHB Securities Research | https://www.rhbgroup.com/ 2024-11-13
Previous report by RHB:
2024-11-12 Riverstone - A Commendable Quarter; Maintain BUY.
Price targets by other brokers at Riverstone Target Prices.
Listing of research reports at Riverstone Analyst Reports.
Relevant links:
Riverstone Share Price History,
Riverstone Announcements,
Riverstone Dividends & Corporate Actions,
Riverstone News Articles
